Platelet‐rich plasma outcomes in knee osteoarthritis are associated with the amount of total deliverable platelets: A systematic review and meta‐analysis
PM&R · 2026-02 · 18 (2) · 210-222
DOI: 10.1002/pmrj.13455 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PM&R, online erschienen am 22.09.2025. Verfasst von Nicholas Hooper und 9 weiteren Autor:innen. Beteiligte Einrichtung: Emory University School of Medicine, Atlanta, USA. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Osteoarthritis, Knee. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Objective
The goal of this study was to examine if differing platelet counts in platelet‐rich plasma (PRP) formulations affected overall pain and function outcomes when compared to hyaluronic acid or placebo control saline injections. Design/Methods We conducted a systematic review and meta‐analysis (International Prospective Register of Systematic Reviews CRD42022340057) evaluating randomized controlled trials comparing injections of PRP to hyaluronic acid (HA) or saline (NS) control in patients with mild or moderate knee osteoarthritis. All studies used a validated outcome measure that examined pain, function, or overall patient global assessment. Study PRP interventions were subclassified as investigating the total number of platelets delivered in a low dose (1–5 billion total deliverable platelets), moderate dose (5–10 billion total deliverable platelets), or high dose (greater than 10 billion total deliverable platelets) injected into the joint.
Results
A total of 32 trials met inclusion criteria. All three PRP groups had significant improvements in validated patient‐reported outcomes when compared to HA. Both the “low” and “high” platelet count groups resulted in a moderate effect size, respectively (standardized mean difference [SMD] = .47; 95% confidence interval [CI] .05–0.89, p < .01; SMD = .68; 95% CI .26–1.09, p < .01). Only the “moderate” (SMD = 1.48; 95% CI .71–2.58 p < .01) platelet count group resulted in large effect size on validated patient‐reported outcomes. When compared to NS, all three PRP groups resulted in significant large effect sizes when examining pain reduction.
Conclusions
When compared to HA, PRP with platelet counts between 1 and 10 billion total deliverable platelets may result in a larger decrease in pain symptoms when compared to platelet counts greater than 10 billion at 6 months. In addition, platelet counts between 5 and 10 billion total deliverable platelets may be associated with greater improvement in functional outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Emory University School of Medicine, Atlanta, USA.
- Department of Physical Medicine and Rehabiliation, Emory University, Atlanta, GA, USA.
- Mayo Clinic, Jacksonville, FL, USA.
- Baylor University, Waco, Tx, USA.
- University of Texas at Austin, Austin, Tx, USA.
- Layfette College, Easton, PA, USA.
ORCID-Profile: Nicholas Hooper
Zitieren
APA
Hooper, N., Shapiro, S., Paidsetty, V., Azarpey, A., Jindal, A., Mautner, K., Easley, K., Buford, D., Sussman, W., & Jayaram, P. (2026). Platelet‐rich plasma outcomes in knee osteoarthritis are associated with the amount of total deliverable platelets: A systematic review and meta‐analysis. PM&R, 18(2), 210-222. https://doi.org/10.1002/pmrj.13455
Vancouver
Hooper N, Shapiro S, Paidsetty V, Azarpey A, Jindal A, Mautner K, et al. Platelet‐rich plasma outcomes in knee osteoarthritis are associated with the amount of total deliverable platelets: A systematic review and meta‐analysis. PM&R. 2026;18(2):210-222. doi:10.1002/pmrj.13455
BibTeX
@article{Hooper2026,
author = {Hooper, Nicholas and Shapiro, Shane and Paidsetty, Vineet and Azarpey, Aydin and Jindal, Alexa and Mautner, Kenneth and Easley, Kirk and Buford, Don and Sussman, Walter and Jayaram, Prathap},
title = {Platelet‐rich plasma outcomes in knee osteoarthritis are associated with the amount of total deliverable platelets: A systematic review and meta‐analysis},
journal = {PM&R},
year = {2026},
volume = {18},
number = {2},
pages = {210--222},
doi = {10.1002/pmrj.13455}
}
EUVIMED